MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer.
about
MiR-183 overexpression inhibits tumorigenesis and enhances DDP-induced cytotoxicity by targeting MTA1 in nasopharyngeal carcinoma.Integrative bioinformatics analysis identifies ROBO1 as a potential therapeutic target modified by miR-218 in hepatocellular carcinoma.overexpression suppresses tumorigenesis of papillary thyroid cancer via inactivation of PTEN/PI3K/AKT pathway by targeting Runx2The Network of Non-coding RNAs in Cancer Drug Resistance
P2860
MicroRNA-218 inhibits tumor growth and increases chemosensitivity to CDDP treatment by targeting BCAT1 in prostate cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
MicroRNA-218 inhibits tumor gr ...... ting BCAT1 in prostate cancer.
@en
type
label
MicroRNA-218 inhibits tumor gr ...... ting BCAT1 in prostate cancer.
@en
prefLabel
MicroRNA-218 inhibits tumor gr ...... ting BCAT1 in prostate cancer.
@en
P2093
P2860
P356
P1476
MicroRNA-218 inhibits tumor gr ...... ting BCAT1 in prostate cancer.
@en
P2093
P2860
P304
P356
10.1002/MC.22612
P577
2017-01-04T00:00:00Z